BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27543727)

  • 21. IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
    Barbey C; Baumgaertner P; Devevre E; Rubio-Godoy V; Derre L; Bricard G; Guillaume P; Luescher IF; Liénard D; Cerottini JC; Romero P; Rufer N; Speiser DE
    J Immunol; 2007 Mar; 178(6):3566-74. PubMed ID: 17339453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells.
    Zhao JJ; Pan K; Wang QJ; Xu ZD; Weng DS; Li JJ; Li YQ; Xia JC
    Chin J Cancer; 2013 Oct; 32(10):553-60. PubMed ID: 23470144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies.
    Harada M; Okamoto T; Omoto K; Tamada K; Takenoyama M; Hirashima C; Ito O; Kimura G; Nomoto K
    Immunology; 1996 Mar; 87(3):447-53. PubMed ID: 8778032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.
    Liu J; Wang L; Wang Y; Zhang W; Cao Y
    PLoS One; 2017; 12(4):e0175704. PubMed ID: 28426690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
    Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
    Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic difference of T cells expanded with anti-CD3 monoclonal antibody in the presence and absence of anti-CD 28 monoclonal antibody.
    Yamada-Ohnishi Y; Azuma H; Urushibara N; Yamaguchi M; Fujihara M; Kobata T; Ikeda H
    Stem Cells Dev; 2004 Jun; 13(3):315-22. PubMed ID: 15186727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
    Oelsner S; Wagner J; Friede ME; Pfirrmann V; Genßler S; Rettinger E; Buchholz CJ; Pfeifer H; Schubert R; Ottmann OG; Ullrich E; Bader P; Wels WS
    Int J Cancer; 2016 Oct; 139(8):1799-809. PubMed ID: 27253354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression.
    Meng Y; Harlin H; O'Keefe JP; Gajewski TF
    J Immunol; 2006 Aug; 177(3):1981-7. PubMed ID: 16849512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.
    Sandberg JK; Fast NM; Nixon DF
    J Immunol; 2001 Jul; 167(1):181-7. PubMed ID: 11418647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin.
    Chen JH; Xiang JY; Ding GP; Cao LP
    J Zhejiang Univ Sci B; 2016 Jul; 17(7):537-44. PubMed ID: 27381730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
    Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
    Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro.
    Li GX; Zhao SS; Zhang XG; Wang WH; Liu J; Xue KW; Li XY; Guo YX; Wang LH
    Mol Med Rep; 2015 Aug; 12(2):2629-35. PubMed ID: 25955083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.
    Hodge G; Barnawi J; Jurisevic C; Moffat D; Holmes M; Reynolds PN; Jersmann H; Hodge S
    Clin Exp Immunol; 2014 Oct; 178(1):79-85. PubMed ID: 24894428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.